Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 38.4% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $73.02. The Score for PCVX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 38.4% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
33
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
58.10

Prediction Charts

Market Cap:
9.4B
Price in USD:
73.02
Volume:
947K
Beta:
1.04

Technical Analysis

SMA50:
82.71
SMA100:
90.34
SMA200:
88.85
52-Wk Change:
-0.31%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 73.02 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-20 83.42 82.47 84.10 82.10
Feb-21 83.77 79.76 84.01 79.51
Feb-25 82.77 79.55 82.77 79.25
Feb-26 82.92 78.65 83.33 78.39
Feb-27 77.87 74.33 78.75 73.88
Feb-28 74.22 73.02 75.26 70.11
Mar-3 73.17 72.11 74.48 71.63
Mar-4 71.29 70.28 72.37 69.38
Mar-5 70.64 73.89 74.10 69.75
Mar-6 72.63 74.81 76.38 71.09
Mar-7 74.06 71.18 75.08 71.12
Mar-11 68.46 69.85 70.25 67.23
Mar-12 70.00 73.24 75.00 70.00
Mar-13 73.07 73.02 76.51 71.69

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.42 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.